**Core Concept**
The question tests the understanding of the physiological effects of electroconvulsive therapy (ECT) on the brain, particularly in the context of **neurotransmitter** regulation and **brain-derived neurotrophic factor (BDNF)**. ECT is a treatment option for severe, treatment-resistant **major depressive disorder**.

**Why the Correct Answer is Right**
ECT has been shown to increase the levels of various **neurotrophic factors**, including BDNF, which plays a crucial role in **neuroplasticity** and **synaptogenesis**. This increase in BDNF is thought to contribute to the therapeutic effects of ECT by enhancing neuronal survival and growth.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because while ECT may have various effects on different neurotransmitter systems, the specific increase related to its therapeutic mechanism is more closely related to neurotrophic factors than to a broad, nonspecific increase in all neurotransmitters.
**Option B:** Incorrect as it does not directly relate to the known primary effects of ECT on the brain.
**Option D:** Incorrect because the primary therapeutic effect of ECT is not directly attributed to a decrease in any particular factor but rather to an increase in factors that promote neuronal health and connectivity.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that ECT's efficacy in treating severe depression is thought to be partly due to its ability to increase **BDNF**, highlighting the importance of neurotrophic factors in mood regulation and the potential for therapies that target these factors.

**Correct Answer:** D. BDNF